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E-mail address: kathryn@chw.edu.au (K.N. North).Biological sensors and their ability to detect and respond to change in the cellular environment can
be modulated by protein scaffolds acting within their interaction network. The skeletal muscle a-
actinins have been considered as primarily structural scaffold proteins. However, deﬁciency of a-
actinin-3 due to a common null polymorphism results in predominantly metabolic changes in skel-
etal muscle function. In this review, we explore the range of phenotypes associated with a-actinin-3
deﬁciency, and draw supporting evidence from known interaction partners for its role as a scaffold
which acts to modulate biological sensors that result in changes in muscle metabolism and
structure.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The a-actinins are a family of four actin-binding proteins (two
muscle and two non-muscle isoforms) that have high sequence
similarity and share a number of functional domains: an N-termi-
nal actin-binding domain, a central rod domain consisting of spec-
trin like repeats, and a C-terminal region that contains EF-hand
motifs (Fig. 1A) [1]. The skeletal muscle a-actinins (encoded by
the ACTN2 and ACTN3 genes) were initially characterized as struc-
tural components of the contractile apparatus of muscle ﬁbres [2].
ACTN2 is expressed in all muscle ﬁbres, whereas ACTN3 has evolved
to have a highly specialised pattern of expression in only fast gly-
colytic muscle ﬁbres [3]. There is a common null polymorphism
(R577X) in ACTN3 that results in absence of a-actinin-3 in more
than one billion humans worldwide [4]. Although the R577X poly-
morphism does not result in any overt disease phenotype, its asso-
ciation with muscle performance has been widely studied in
athletes from around the world [5]. The R allele is advantageous
and the X allele is detrimental in sports which require muscle
strength and power; the X allele demonstrates some beneﬁt in
sports that require muscle endurance, although the association ischemical Societies. Published by E
ce and Muscle Research, The
, Australia.less strong [6]. In addition, ACTN3 genotype contributes to varia-
tion in muscle strength within the general population [7,8].
Intriguingly, ACTN3 is one of only two genes in humans in which
positive selection for a null mutation [9] (i.e. X allele) along with
a higher frequency in non-African populations, has been identiﬁed
to date – suggesting a selective advantage within the Eurasian
environment [4].
In order to study the effects of a-actinin-3 deﬁciency on muscle
function, the Actn3 knockout (KO) mouse was generated. The clo-
sely related protein, a-actinin-2, is up-regulated and expressed in
all ﬁbre types in KO mice, similar to the expression pattern seen
in human muscle. The increased expression of a-actinin-2 in fast
glycolytic muscle ﬁbres is sufﬁcient to avoid muscle disease but
does not completely compensate for the absence of a-actinin-3.
At the physiological level, Actn3 KO mice have decreased muscle
strength, enhanced muscle endurance and a signiﬁcant reduction
in muscle mass compared to wild-type (WT) due to decreased
diameter of fast twitch (2B) muscle ﬁbres in which a-actinin-3 is
expressed [4,10]. In addition, isolated Actn3 KO muscles have long-
er twitch half-relaxation times and enhanced recovery from fatigue
compared to WT [11]. At the molecular level, KO muscle ﬁbres
showed an overall increase in glycogen content, while fast ﬁbres
display signiﬁcantly decreased activity of enzymes in the anaerobic
pathway and increased activity of mitochondrial enzymes in the
oxidative pathway [4,10]. Taken together, these observationslsevier B.V. All rights reserved.
Fig. 1. (A) The highly conserved domain structure of a-actinin which contains an actin-binding domain, four spectrin repeats and EF-hand domains. (B) Surface
representation of a-actinin rod domain (1HCI), aligned with spectrin repeat 1 on the left and spectrin repeat 4 on the right. The colors grey, blue and red represent identical,
conservative and non-conservative residue substitutions when a-actinin-2 and -3 vertebrate sequences are aligned.
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thus provide an explanation for poorer sprint and improved endur-
ance performance in ACTN3 XX humans.
Despite comprehensive characterization of the Actn3 KO mouse
model, the underlying molecular mechanisms that link the absence
of a structural protein to the reported phenotype remains elusive.
Staining for myosin heavy chain isoforms (MyHC) demonstrate no
changes in ﬁbre type proportions in KO muscle. In contrast, trans-
genic mice modelling the effects of alterations in PGC-1a, PPAR,
calsarcin-2 and calcineurin on muscle metabolism all show an acti-
vation of slow oxidative gene programs resulting in a shift to a
slow oxidative phenotype and increased numbers of slow ﬁbres
as deﬁned by MyHC. Similarly, the ablation of metabolic enzymes,
glycogen synthase [12], hormone sensitive lipase [13] and phosp-
hofructo-1-kinase [14] also induce shifts in ﬁbre types through
the activation of gene programs which couple metabolic and struc-
tural muscle gene expression. In contrast, the ablation of structural
proteins, desmin [15], myotilin [16], ab-crystallin [17], myosin
heavy chain IIb and IIx [18], can produce structural abnormalities
but do not cause a shift in metabolic properties or ﬁbre types. Thus,
the structural protein a-actinin-3 is unique in its ability to induce a
shift in both metabolic and structural properties of muscle ﬁbres
without inﬂuencing muscle ﬁbre type as deﬁned by the expression
of myosin heavy chain isoform.
In this review, we deﬁne a biological sensor as a protein or pro-
tein complex with the ability to detect signals in the form of energy
(e.g. electrical, mechanical) or molecules (calcium) and respond by
activating or modulating biological processes. The biological sen-
sors, calmodulin (calcium sensor) [19], voltage gated potassium
channel (electrical) [20] and the cardiac stretch sensor (mechani-
cal) [21] are examples of well-characterized sensors. The ability
to detect and respond to changing extra-cellular and intra-cellular
environments is critical for cell survival. Hence, the ability of a bio-
logical sensor to detect changing environments serves as an impor-
tant precursor to cellular response.
The sarcomeric a-actinins (a-actinin-2 and -3) are notable
amongst the structural proteins in their ability to interact with a
diverse range of structural, membrane, signalling and metabolic
proteins [1]. For a comprehensive review of a-actinins and their
interaction partners, refer to the follow reviews [1,22,23]. In addi-
tion to proteins, a-actinin binds to calcium [24] and PIP2 [25]
which regulates its afﬁnity for actin. The functional EF-hand do-
mains within the non-muscle actinins allow them to behave as a
calcium sensor responsible for cytoskeletal remodelling [26]. This
function is conserved in all invertebrate actinins and non-muscle
actinins but appears to be lost due to deletion in the EF-hand in
some vertebrate skeletal muscle (sarcomeric) a-actinins including
in humans and mice [27]. The a-actinin rod domain is composed offour spectrin like repeats and mediates the majority of these inter-
actions. Furthermore, at a protein complex level, a-actinins form
components of sensor machinery through direct protein interac-
tions both at the membrane (voltage, ligand and mechanical
stretch sensors) and the Z-line (mechanical stretch, calcium and
metabolic sensors). Although the sarcomeric a-actinins do not
function as sensors themselves, they act as scaffolds and have been
shown to play a role in regulation in terms of number, location and
activation threshold of sensors. Interestingly, mutations within a-
actinin-2 and its interaction partners of the sensor machinery re-
sult in cardiomyopathy due to altered binding afﬁnity [28–30].
The protein sequence of a-actinin-2 and a-actinin-3 are 80% iden-
tical [3] and thus sites which differ are effectively missense muta-
tions. The conservation of non-conservative residue changes since
the duplication and divergence of a-actinin-2 and a-actinin-3
(Fig. 1B) may contribute to subtle differences in protein interaction
such as selectivity amongst interaction partners for a speciﬁc sar-
comeric isoform. In the absence of a-actinin-3 we propose three
general possibilities that may alter the function of sensor machin-
ery: (1) The absence of a-actinin-3 speciﬁc interactions and the
presence of a-actinin-2 speciﬁc interaction within fast glycolytic
ﬁbres. (2) Altered protein complex stability due to changes in afﬁn-
ity for a-actinin-2. (3) Fast muscle ﬁbres deﬁcient in a-actinin-3
may be more susceptible to damage and release proteins capable
of transport to the nucleus (Fig. 2). This provides an alternate pro-
tein interaction framework to explain how muscle ﬁbre properties
can be changed, and these changes may lie upstream to those in-
duced by PGC1-a, PPAR and calcineurin pathways. On this basis
we have reviewed the known protein interactions of the sarco-
meric a-actinins, with a focus on deﬁning the biological sensors
that may be modulated by the a-actinins to induce changes in
muscle metabolism and structure without altering ﬁbre type
speciﬁcation.
2. Membrane sensors
The localization of channels and receptors on the cell mem-
brane allows them to act as biological sensors that detect extra-cel-
lular signals such as molecules, mechanical and electrical
signalling. The a-actinins interact with a diverse range of channels
and receptors which make up the sensor machinery, and thus have
a much more diverse role than the ‘‘structural” role that they were
originally thought to play in maintaining Z-line structure and an
ordered myoﬁbrillar array [2]. The sarcomeric a-actinins have
now been shown to interact with, and modify, the properties of
the following sensors at the membrane: (1) Interactions with a-ac-
tinin regulate the membrane density for the adenosine A2A [31]
and acetylcholine receptors [32] and the ion channels Kv1.5 [33]
Fig. 2. The sarcomeric actinins dimerise to cross-link actin at the Z-line. The blue and red dimers represent a-actinin-2 and a-actinin-3, respectively. (A) There may be
interactions with a-actinin-2 or -3 which are isoform speciﬁc. These interactions are represented by a yellow triangle or green rounded rectangle. Within a protein interaction
framework, we propose three broad scenarios which can occur in the absence of a-actinin-3. (B) Interactions which are a-actinin-3 speciﬁc are lost. (C) Interactions which are
a-actinin-3 speciﬁc still occur but with reduced binding afﬁnity. This may effect the activation threshold of sensors at the membrane. (D) Fast ﬁbres that are deﬁcient in a-
actinin-3 are more susceptible to damage and may release sensors that normally localize to the Z-line.
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currents. (2) a-Actinin is required for channel activation of polycy-
stin-2 [35], TRPP3 [36] and the L-type Ca2+ channels [37]. (3) a-Ac-
tinin plays an essential role in the insulin and phosphorylation
dependent transport of GLUT4 [38] and AMPA receptor subunit
Glu4 [39], respectively. (4) a-Actinin has the ability to interact
with multiple proteins simultaneously and is thought to act as a
molecular bridge between SK2 and L-type Ca2+ channels and also
between b-integrin and dystrophin. In the case of SK2 and L-type
Ca2+ channel this allows the calcium activated SK2 channel to be
in close proximity to a source of Ca2+ ions [40]. In contrast, the
bridge between b-integrin and dystrophin provides a link between
the muscle cytoskeleton and the extra-cellular matrix allowing
mechanical force to be transduced along this link [41]. (5) a-Acti-
nin can act to modulate the behaviour of a receptor through com-
petitive binding. For example, a-actinin and calmodulin compete
for the same interaction sites on the NMDA NR1 subunit. At resting
intraceullar calcium levels, a-actinin binds to NR1 and is displaced
and inactivated by calmodulin at higher calcium levels [42].
All of the above interactions were characterized using a-acti-
nin-2 except for AMPA and GLUT4 which were shown to interactwith the non-muscle actinins, a-actinin-1 and -4 respectively.
Although the four a-actinins are highly similar, subtle sequence
differences may be mediating isoform speciﬁc interactions. There
are three reports of functional differences between the different
a-actinin isoforms: (1) GLUT4 transport was reported to be a-acti-
nin-4 dependent, while down-regulation of a-actinin-1 had no ef-
fect on transport [38]. (2) Expression of chicken a-actinin-2 and
not non-muscle a-actinin was able to reduce the inactivation of
the L-type Ca2+ channel [37]. (3) Adenosine A2A receptor shows a
binding preference to a-actinin-3, however there are no reports
on functional signiﬁcance of this preference [31]. Therefore, given
the ability of a-actinins to modulate sensor behaviour at the mem-
brane, it is possible that substitution and up-regulation with an-
other a-actinin isoform may also have the ability to alter sensor
behaviour at the muscle Z-line.
3. Mechanical sensor
The Z-line proteins, titin, telethonin/TCAP and muscle LIM pro-
tein (MLP) have been proposed to play a role in mechanical
sensing in the heart [21]. Within the heart this sensor detects
Fig. 2 (continued)
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enhance myocardial cell survival which prevents dilated cardiomy-
opathies [43]. Despite a-actinin-2 interacting with both titin and
MLP and ACTN2 mutations resulting in cardiomyopathy, the role
of a-actinin-2 in the stretch sensor has been largely neglected.
MLP, (also known as cysteine rich protein CRP3), is predomi-
nantly expressed in striated muscle and localizes to the cytoplasm
[44], nucleus [45] and myoﬁbrillar structures [46]. The interaction
between MLP and a-actinin allows MLP to be localized at the Z-line
[28] from which it can detect and respond to mechanical stimuli
[47]. A recent study proposed that MLP predominately localizes
to the cytoplasm and not myoﬁbrillar structures. This suggests
MLP may not be localized in a position to receive mechanical sig-
nals and instead acts as a signal transducer for the mechanical sen-
sor [44]. MLP has the ability to translocate to the nucleus and
activate myogenic transcription factors which include MyoD,
myogenin and MRF4 [48]. Thus, MLP mediates the activation of
myogenic gene programs upon receiving or transducing mechani-
cal stimuli. There are a number of lines of evidence to suggest that
absence of a-actinin-3 or up-regulation of a-actinin-2 may alter
the function of the mechanical sensor, MLP and lead to reduced
type 2B muscle ﬁbre size and reduced muscle mass in a-actinin-3 deﬁcient muscle. First, the site of a-actinin interaction on MLP
is close to a predicted nuclear localize signal (NLS) which may
tether MLP to the Z-line and only unmask the NLS when transport
to the nucleus is required. Second, interaction with MLP is lost in
the a-actinin-2 Q9R mutation resulting in dilated cardiomyopathy
[28]. In addition, recently identiﬁed mutations in a-actinin-2 may
also effect the binding to various proteins within the mechanical
sensor machinery [49]. Conversely, cardiomyopathy-causing
mutations in MLP [29] and titin [30] result in reduced binding
afﬁnity for a-actinin-2. Finally, the over expression of myogenin
(an activation target of MLP) activates expression of genes involved
in oxidative metabolism and a decrease in type 2B ﬁbre size [50].
4. Calcium sensor
The calcium ion is an essential intra-cellular signalling molecule
which varies in concentration during contraction in muscle [51].
This allows muscle to use intra-cellular calcium concentrations
as a measure of muscle activity and adapt accordingly. Within
muscle the calcium/calmodulin-dependent phosphatase, calcineu-
rin is the major calcium sensor responsible for ﬁbre type switching
and hypertrophy [52]. At the muscle Z-line, calsarcins and atrogin-
2978 M. Lek, K.N. North / FEBS Letters 584 (2010) 2974–29801 form two important complexes involved in modulating the calci-
neurin pathway. The a-actinins interact with calsarcin and atrogin-
1 and thus modulation of the calcineurin pathway in the Actn3 KO
may contribute to the shift to a more oxidative muscle phenotype
and reduced type 2B ﬁbre size.
The calsarcins (also known as FATZ and myozenin) contain
three family members, calsarcin-1 which is expressed in heart
and type 1 muscle ﬁbres and calsarcin-2 and -3 which are predom-
inantly expressed in type 2 muscle ﬁbres [53–55]. The main func-
tion of calsarcins is to inhibit and localize calcineurin to the Z-line
through interaction with a-actinin [56]. Hence, the ablation of the
calsarcins results in the activation of the calcineurin pathway
which is observed in the calsarcin-1 [57] and -2 KO mice [58]. As
a consequence, there is a ﬁbre type switch towards slow oxidative
ﬁbres thought to underlie the enhanced endurance capacity in the
calsarcin-2 KO mouse. In fact, the Actn3 and calsarcin-2 KO are the
only two examples to date where loss of function has resulted in an
enhanced endurance phenotype [58]. The calsarcins contain multi-
ple overlapping interaction sites facilitating the interaction with a-
actinin, ﬁlamin C, telethonin, calcineurin [53] and the PDZ/LIM
family [59]. The overlapping binding sites on the calsarcins creates
competition between binding partners which is observed with a-
actinin inhibiting the binding of ﬁlamin C in a dose-dependent
manner [55]. Interestingly, a-actinin and calcineurin also have an
overlapping binding site [53] and thus competition for this site
may be affected by the absence of a-actinin-3 or up-regulation of
a-actinin-2.
The muscle and cardiac speciﬁc F-box protein, atrogin-1/muscle
atrophy F-box (MAFbx) forms the targeting component of the SCF
ubiquitin ligase complex [60]. Overexpression of atrogin-1 targets
MyoD for degradation resulting in myotube atrophy. Conversely,
atrogin-1 deﬁcient mice are resistant to muscle atrophy [61]. In
skeletal muscle, atrogin-1 localizes to the Z-line through its inter-
action with a-actinin. Atrogin-1 modulates the calcineurin path-
way by interaction and ubiquitination of calcineurin A, hence
targeting it for degradation [62]. Interestingly, the a-actinin inter-
action site on atrogin-1 is in close proximity to the NLS and calci-
neurin A binding site [62], suggesting a possible role for a-actinin
in regulating the translocation of atrogin-1 to the nucleus where it
can target MyoD [63] and myogenin [64] for degradation.5. Metabolic sensor
In skeletal muscle the metabolic processes of glycolysis and gly-
coneogenesis are thought to be compartmentalised within the I-
band and Z-line, respectively [65]. The glycolytic enzymes, phos-
phofructokinase, aldolase and pyruvate kinase achieve this
through their binding afﬁnity for thin ﬁlament proteins such as ac-
tin [66], while the glyconeogenesis complex is formed at the Z-line
through attaching to sarcomeric a-actinin [67]. The metabolic en-
zymes, glycogen phosphorylase [68], glycogen synthase [69] and
fructose 1,6-bisphosphatase (FBPase) [67] localize to the Z-line,
however only the key enzyme of glyconeogenesis, FBPase acts as
a metabolic sensor.
The glyconeogenesis complex is composed of FBPase, aldolase
and a-actinin [67]. Within the complex, FBPase acts as a metabolic
sensor, which senses and is inhibited by the metabolites, fructose
2,6-bisphosphate and AMP. The formation of the complex is regu-
lated by calcium levels and cannot form when calcium concentra-
tion is high [70]. Thus, FBPase-mediated glyconeogenesis only
occurs during times of recovery or inactivity. In addition to calcium
regulation, AMP and fructose 2,6-bisphosphate inhibition prevents
the unnecessary consumption of ATP (futile cycle). The interaction
between FBPase and aldolase serves two purposes. First, muscle
FBPase is strongly inhibited by AMP and should have no activityin muscle, however the interaction with aldolase removes this
inhibition [71]. In addition, the interaction with aldolase attached
to fructose 1,6-bisphosphate allows FBPase to be in close proximity
to its substrate (channelling) [72]. The interaction between FBPase
and the sarcomeric a-actinins allows the glyconeogenic complex to
be localized at the Z-line in skeletal [67] and cardiac muscle [73].
Besides localize to the Z-line, muscle FBPase also localizes to the
nucleus in a developmental dependent manner [74], however its
exact function in the nucleus is unknown.
In the Actn3 KO mouse, there is upregulation of a-actinin-2 to
compensate for loss of a-actinin-3 which appears to alter the inter-
action with the metabolic sensor, FBPase. This may explain the in-
crease in glycogen content and activity in enzymes involved in
aerobic metabolism associated with a-actinin-3 deﬁciency. There
are several lines of evidence to support this. In smooth muscle,
cytoplasmic FBPase does not localize to non-muscle actinins [75]
suggesting the interaction between muscle FBPase is speciﬁc to
sarcomeric actinins. Furthermore, FBPase complex formation is
insensitive to calcium at the cardiac intercalated disc [73], which
suggests a-actinin-2 (the only sarcomeric actinin in the heart)
has altered interaction properties. In addition, although the inter-
action sites on a-actinin and FBPase have not been determined,
a-actinin may play an additional role in masking the NLS of FBPase
[76] preventing its translocation to the nucleus while attached at
the Z-line. While the role of FBPase in the nucleus is unknown, cel-
lular localization of liver FBPase has been linked to glycogen for-
mation [77]. Last, FBPase activity in mouse muscle was only
detected in fast muscle ﬁbres, with glycolytic ﬁbres having higher
activity [78]. Hence, expression of FBPase is fast ﬁbre speciﬁc or re-
quires fast ﬁbre speciﬁc proteins in order to be active. We have
proposed that a-actinin-3 has functionally diverged from a-acti-
nin-2 after gene duplication resulting in fast ﬁbre speciﬁc interac-
tions and functions [26]. Similarly, there may be additional
functional divergence from liver FBPase besides AMP inhibition
[79] which has given muscle FBPase tissue speciﬁc functions. The
alteration in muscle metabolism observed in the muscle phospho-
fructokinase (PFK) KO mice (PFK is activated by fructose 1,6-bis-
phosphate) [14] and PEPCK-C (another key enzyme in
glyconeogenesis) transgenic mice [80] provides a precendent for
possible alterations caused by muscle FBPase.6. Conclusion
The actinins play a role in modulating the function of sensors at
the membrane and in this review we have highlighted evidence
which suggests actinin may also modulate sensor behaviour at
the Z-line. The alterations of mechanical, calcium and metabolic
sensors at the Z-line results in possible phenotypes which are com-
mon to those observed in a-actinin-3 deﬁciency. Within a protein
interaction framework, absence of a-actinin-3 could result in loss
of interactions or new interactions with a-actinin-2 which nor-
mally do not occur in fast muscle ﬁbres [26]. In addition, up-regu-
lation of a-actinin-2 expression may also affect stoichiometry in
which protein complexes form. The ability of a-actinin to dock pro-
teins to the Z-line preventing their transport to the nucleus is com-
mon to all sensing machinery above. In addition, sarcomeric
actinins play a similar docking role in their interaction with the
myopodin signalling complex [81], FHL3 [82] and the downstream
targets of MEF2A, myomaxin [83] and myospryn [84]. In the Actn3
KO, there is up-regulation of desmin, myotilin and ab-crystallin
[unpublished data], which likely reﬂects myoﬁbrillar remodelling
[85]. In addition, upon eccentric contraction there is an increased
suspectibility to damage in a-actinin-3 deﬁcient ﬁbres [unpub-
lished data]. Taken together, structural stability and release of
important nuclear shuttling proteins at the Z-line provides an
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are other important examples of genetic compensation resulting in
altered muscle function. The dystrophin-deﬁcient mdx mouse
muscle disease phenotype is more severe when its genetic backup,
utrophin is also absent in double KO mice [86]. Similarly, the myo-
tilin-deﬁcient mouse only shows a disease phenotype when its ge-
netic backup, myopalladin is knocked out. Lastly, morbidity in
skeletal muscle a-actin deﬁcient mice can be rescued by heterolo-
gous expression of cardiac (fetal) a-actin [87]. Therefore, under-
standing the protein interaction framework surrounding the
structural protein, a-actinin will provide insight into the mecha-
nism of genetic backup and its effects on normal muscle variation.References
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